Journal article · 2018 · Open access

2-Mercapto-Quinazolinones as Inhibitors of Type II NADH Dehydrogenase and Mycobacterium tuberculosis : Structure–Activity Relationships, Mechanism of Action and Absorption, Distribution, Metabolism, and Excretion Characterization

Dinakaran Murugesan, Peter C. Ray, Tracy Bayliss, Gareth A. Prosser, Justin R. Harrison, Kirsteen Green, Candice Soares de Melo, Tzu‐Shean Feng, Leslie J. Street, Kelly Chibale, Digby Francis Warner, Valerie Mizrahi and 19 more

ACS Infectious Diseases, 4(6), 954–969 · Published 9 March 2018 · DOI 10.1021/acsinfecdis.7b00275

Open full textCite this paper

In brief

“2-Mercapto-Quinazolinones as Inhibitors of Type II NADH Dehydrogenase and Mycobacterium tuberculosis : Structure–Activity Relationships, Mechanism of Action and Absorption, Distribution, Metabolism, and Excretion Characterization” is a 2018 journal article by Dinakaran Murugesan and 30 co-authors, published in ACS Infectious Diseases. OpenAlex counts 89 citations as of 21 November 2026, which puts it in the top 7% of works published in 2018 by citations. It is open access under a CC BY licence: the full text is free to read at ACS Infectious Diseases.

Citations
89
Most cited in
2026 (15)
Field-weighted impact
5.20
References
48
Authors
31

Abstract

Mycobacterium tuberculosis ( MTb) possesses two nonproton pumping type II NADH dehydrogenase (NDH-2) enzymes which are predicted to be jointly essential for respiratory metabolism. Furthermore, the structure of a closely related bacterial NDH-2 has been reported recently, allowing for the structure-based design of small-molecule inhibitors. Herein, we disclose MTb whole-cell structure-activity relationships (SARs) for a series of 2-mercapto-quinazolinones which target the ndh encoded NDH-2 with nanomolar potencies. The compounds were inactivated by glutathione-dependent adduct formation as well as quinazolinone oxidation in microsomes. Pharmacokinetic studies demonstrated modest bioavailability and compound exposures. Resistance to the compounds in MTb was conferred by promoter mutations in the alternative nonessential NDH-2 encoded by ndhA in MTb. Bioenergetic analyses revealed a decrease in oxygen consumption rates in response to inhibitor in cells in which membrane potential was uncoupled from ATP production, while inverted membrane vesicles showed mercapto-quinazolinone-dependent inhibition of ATP production when NADH was the electron donor to the respiratory chain. Enzyme kinetic studies further demonstrated noncompetitive inhibition, suggesting binding of this scaffold to an allosteric site. In summary, while the initial MTb SAR showed limited improvement in potency, these results, combined with structural information on the bacterial protein, will aid in the future discovery of new and improved NDH-2 inhibitors.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Murugesan, D., Ray, P. C., Bayliss, T., Prosser, G. A., Harrison, J. R., Green, K., de Melo, C. S., Feng, T., Street, L. J., Chibale, K., Warner, D. F., Mizrahi, V., Epemolu, O., Scullion, P., Ellis, L. C., Riley, J., Shishikura, Y., Ferguson, L., Osuna‐Cabello, M., . . . Boshoff, H. I. (2018). 2-Mercapto-Quinazolinones as Inhibitors of Type II NADH Dehydrogenase and Mycobacterium tuberculosis : Structure–Activity Relationships, Mechanism of Action and Absorption, Distribution, Metabolism, and Excretion Characterization. ACS Infectious Diseases, 4(6), 954–969. https://doi.org/10.1021/acsinfecdis.7b00275

MLA 9

Murugesan, Dinakaran, et al. “2-Mercapto-Quinazolinones as Inhibitors of Type II NADH Dehydrogenase and Mycobacterium tuberculosis : Structure–Activity Relationships, Mechanism of Action and Absorption, Distribution, Metabolism, and Excretion Characterization.” ACS Infectious Diseases, vol. 4, no. 6, 2018, pp. 954–969. https://doi.org/10.1021/acsinfecdis.7b00275.

Chicago

Murugesan, Dinakaran, Peter C. Ray, Tracy Bayliss, Gareth A. Prosser, Justin R. Harrison, Kirsteen Green, Candice Soares de Melo, et al. 2018. “2-Mercapto-Quinazolinones as Inhibitors of Type II NADH Dehydrogenase and Mycobacterium tuberculosis : Structure–Activity Relationships, Mechanism of Action and Absorption, Distribution, Metabolism, and Excretion Characterization.” ACS Infectious Diseases 4 (6): 954–969. https://doi.org/10.1021/acsinfecdis.7b00275.

Harvard

Murugesan, D. et al. (2018) ‘2-Mercapto-Quinazolinones as Inhibitors of Type II NADH Dehydrogenase and Mycobacterium tuberculosis : Structure–Activity Relationships, Mechanism of Action and Absorption, Distribution, Metabolism, and Excretion Characterization’, ACS Infectious Diseases, 4(6), pp. 954–969. doi:10.1021/acsinfecdis.7b00275.

IEEE

D. Murugesan et al., “2-Mercapto-Quinazolinones as Inhibitors of Type II NADH Dehydrogenase and Mycobacterium tuberculosis : Structure–Activity Relationships, Mechanism of Action and Absorption, Distribution, Metabolism, and Excretion Characterization,” ACS Infectious Diseases, vol. 4, no. 6, pp. 954–969, 2018, doi: 10.1021/acsinfecdis.7b00275.

BibTeX

@article{murugesan2018mercapto,
  title     = {{2-Mercapto-Quinazolinones as Inhibitors of Type II NADH Dehydrogenase and Mycobacterium tuberculosis : Structure–Activity Relationships, Mechanism of Action and Absorption, Distribution, Metabolism, and Excretion Characterization}},
  author    = {Murugesan, Dinakaran and Ray, Peter C. and Bayliss, Tracy and Prosser, Gareth A. and Harrison, Justin R. and Green, Kirsteen and de Melo, Candice Soares and Feng, Tzu‐Shean and Street, Leslie J. and Chibale, Kelly and Warner, Digby Francis and Mizrahi, Valerie and Epemolu, Ola and Scullion, Paul and Ellis, Lucy C.J. and Riley, Jennifer and Shishikura, Yoko and Ferguson, Liam and Osuna‐Cabello, Maria and Read, Kevin D. and Green, Simon R. and Lamprecht, Dirk A. and Finin, Peter M. and Steyn, Adrie J. C. and Ioerger, Thomas R. and Sacchettini, J.C. and Rhee, Kyu Young and Arora, Kriti and Barry, Clifton E. and Wyatt, Paul Graham and others},
  journal   = {ACS Infectious Diseases},
  year      = {2018},
  volume    = {4},
  number    = {6},
  pages     = {954--969},
  doi       = {10.1021/acsinfecdis.7b00275},
  url       = {https://doi.org/10.1021/acsinfecdis.7b00275}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201822
201988
20201111
20211010
20221313
20231010
202477
20251313
20261515

Its field-weighted citation impact is 5.20: it has been cited 5.20 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology

  • NDH-2
  • Mycobacterium tuberculosis
  • structure-activity relationship
  • glutathione adducts
  • pharmacokinetics
  • drug resistance
  • electron transport chain
  • non-competitive inhibition

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Murugesan, D., Ray, P. C., Bayliss, T., Prosser, G. A., Harrison, J. R., Green, K., de Melo, C. S., Feng, T., Street, L. J., Chibale, K., Warner, D. F., Mizrahi, V., Epemolu, O., Scullion, P., Ellis, L. C., Riley, J., Shishikura, Y., Ferguson, L., Osuna‐Cabello, M., . . . Boshoff, H. I. (2018). 2-Mercapto-Quinazolinones as Inhibitors of Type II NADH Dehydrogenase and Mycobacterium tuberculosis : Structure–Activity Relationships, Mechanism of Action and Absorption, Distribution, Metabolism, and Excretion Characterization. ACS Infectious Diseases, 4(6), 954–969. https://doi.org/10.1021/acsinfecdis.7b00275

How many times has this paper been cited?

89 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at ACS Infectious Diseases: sign in and open the full text from this page.

Who wrote this paper?

Dinakaran Murugesan, Peter C. Ray, Tracy Bayliss, Gareth A. Prosser, Justin R. Harrison, Kirsteen Green, Candice Soares de Melo, Tzu‐Shean Feng, Leslie J. Street, Kelly Chibale, Digby Francis Warner, Valerie Mizrahi and 19 more.

What is the DOI of this paper?

10.1021/acsinfecdis.7b00275, permanently at https://doi.org/10.1021/acsinfecdis.7b00275. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.